Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population

BACKGROUND: HER2 status is a predictive biomarker of response to trastuzumab in advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. However, there is relatively little known about the role of HER2 in resected gastric or GEJ adenocarcinoma in the Western population. METHODS: Retrospec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ecancermedicalscience
Main Authors: Lago, Nieves Martínez, Villar, María Vieito, Ponte, Rafael Varela, Nallib, Ihab Abdulkader, Alvarez, Juan José Carrera, López, José Ramón Antúnez, López, Rafael López, Iruegas, María Elena Padin
Formato: Artigo
Idioma:Inglês
Publicado em: Cancer Intelligence 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7105341/
https://ncbi.nlm.nih.gov/pubmed/32256703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2020.1020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados